Scarica l'app Stockscreener
48.11
8.21%
3.65
Dopo l'orario di chiusura:
48.00
-0.11
-0.23%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché HIMS Giù?
Forum
Previsione
Hims Hers Health Inc Borsa (HIMS) Ultime notizie
Hers Health Inc. in sector analysis2025 Earnings Surprises & Fast Moving Market Watchlists - Newser
Hims & Hers Health: A Disruptive Force in Personalized Digital Healthcare and Its Implications for Long-Term Growth - AInvest
Exclusive: Remedy Meds to acquire Thirty Madison - Axios
Hims & Hers (HIMS) Steals Spotlight as Court Junks Eli Lilly Lawsuit vs 4 Telehealth Firms - MSN
Why Hims & Hers Health (HIMS) Stock Is Up Today - TradingView
Sustainable weight loss with Hims & Hers - fox10tv.com
Experts discuss the impact of limited insurance coverage on obesity treatment access - KOKH
BofA Securities maintains Underperform rating on Hims and Hers stock By Investing.com - Investing.com Australia
4 Top Stocks to Buy in September - The Motley Fool
HIMS Stock Climbs 7% after Eli Lilly’s Knockoff Case Falls Flat - TipRanks
Navigating the Storm: Hims & Hers' Legal Resilience in the Telehealth and Compounded Drug Sector - AInvest
Eli Lillys 036 Gains Overshadowed by 3075 Volume Drop as Court Dismisses Lawsuit Stock Ranks 33rd in Market Activity Amid Hims Surge - AInvest
Strategic Capital Moves in Disruptive Consumer & Mobility Sectors: Lyft, Hims & Hers, and Constellation Brands - AInvest
Noteworthy Wednesday Option Activity: HIMS, UNH, SMMT - Nasdaq
Lyft convertible notes, Hims & Hers surges, Constellation Brands - Yahoo Finance
Hims & Hers Health Stock (HIMS) Opinions on Telehealth Innovation and Recent Setbacks - Quiver Quantitative
Hims & Hers gains after court rejects Eli Lilly’s case against Willow - Yahoo Finance
Hims & Hers Health Set to Meet Revenue Projections Amid Growing Confidence - StocksToTrade
Hims & Hers Sees Revenue Growth Amid Deutsche Bank’s Optimistic Outlook - timothysykes.com
Hers Health Inc.Weekly Market Report & Community Consensus Picks - Newser
Here is What to Know Beyond Why Hims & Hers Health, Inc. (HIMS) is a Trending Stock - Yahoo Finance
HIMS' Personalized Wellness Platform Expands Preventive Care Access - sharewise.com
Hers Health Inc. holdersEarnings Overview Report & Daily Stock Trend Reports - Newser
Hers Health Inc. reversing from oversold territoryLayoff News & Accurate Buy Signal Notifications - Newser
Hims & Hers Health: Still Undervalued (NYSE:HIMS) - Seeking Alpha
Hers Health Inc. stock trend forecastRisk Management & Reliable Volume Spike Trade Alerts - Newser
Hers Health Inc. bounce back from current support2025 Price Targets & AI Enhanced Trading Signals - Newser
Insider Moves: Datadog, Hims & Hers, Opendoor, Texas Instruments, Vertiv - TipRanks
Hers Health Inc.’s reversalGap Down & Stock Timing and Entry Methods - Newser
Hims & Hers: The Dominant Health Platform Of The Future (NYSE:HIMS) - Seeking Alpha
Real time social sentiment graph for HIMSNew Guidance & Safe Entry Trade Reports - Newser
Hers Health Inc. stock entering bullish territoryTrade Exit Report & Growth Focused Entry Reports - Newser
Hims & Hers Climbs to 102nd in Market Activity With $790M Volume as Insider Sales and Mixed Earnings Spark Doubts - AInvest
Hims & Hers Health Insider Selling: Signal of Distrust or Strategic Rebalancing? - AInvest
Hers Health Inc. in the next 30 daysPortfolio Growth Summary & Weekly Top Gainers Alerts - Newser
HIMS vs. AMWL: Which Stock Has the Stronger Global Growth Strategy? - The Globe and Mail
Hims & Hers Health Stock Plunges 2.95% as Trading Volume Falls 32% to $890M and Drops to 67th in Activity - AInvest
Hims & Hers’ growth prospects clouded by Novo dispute and regulatory scrutiny - S&P Global
HIMS & HERS ALERT: Bragar Eagel & Squire, P.C. is - GlobeNewswire
Hims & Hers Scales Growth Through Subscriptions and Care Expansion - sharewise.com
Hims & Hers Health Is Looking to Cash In on This Novo Nordisk Blunder - ca.finance.yahoo.com
Hims & Hers Health Clears Key Benchmark, Hitting 90-Plus RS Rating - Investor's Business Daily
Hers Health Inc. stock performanceQuarterly Trade Review & Daily Growth Stock Investment Tips - Newser
Hims & Hers Stocks: Join the Pharma Boom? - StocksToTrade
Hims & Hers Health Stock (HIMS) Opinions on Telehealth Disruption and Recent Challenges - Quiver Quantitative
Hims & Hers Health Surges 5.15% on Intraday Rally—What’s Fueling the Momentum? - AInvest
Hims & Hers' Resilience Amid GLP-1 Market Shifts: Short-Term Volatility vs. Long-Term Personalized Care Positioning - AInvest
Hims & Hers Health, Inc. Class Action: Levi & Korsinsky - GlobeNewswire
Hims & Hers: Navigating Short-Sellers and Regulatory Storms in the DTC Healthcare Sector - AInvest
Levi & Korsinsky Helps Shareholders SueWallSt After Hims & Hers Health, Inc. Stock Drops - Stockhouse
Hims & Hers Health: Navigating Regulatory Storms and Rebuilding a Growth Narrative - AInvest
Hims & Hers: A Case Study in Governance and Partnership Risks in the Digital Health Sector - AInvest
2.74%
4.86%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):